Who are Trialtus Bioscience's investors?

Trialtus Bioscience's investors include Innovation Depot.

How much funding has Trialtus Bioscience raised?

Trialtus Bioscience has disclosed $1.6M raised across 1 round.

Where is Trialtus Bioscience headquartered?

Trialtus Bioscience is headquartered in Birmingham, US.

Trialtus Bioscience

Birmingham, US · Founded 2017 · Delaware LLC · 1 known investors

Find your way into Trialtus Bioscience

Paths you didn't know you had: your email and LinkedIn already hold routes to the Trialtus Bioscience team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Trialus Bioscience provides protein purification products and services for laboratory and research applications.

Biotech Deep Tech

Founders & leadership

Robert ShufflebargerChief Executive Officer of the Issuer

Investors · 1

Innovation Depotlisted by Innovation DepotBirmingham

How we know: Innovation Depot's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 1 round · 2018

▶$1.6MraisedApr 2019 · 13 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Robert ShufflebargerExecutive Officer

Offering amount: $2M
Amount sold: $1.6M
Minimum investment: $25K
First sale: May 2018
Incorporated: Limited Liability Company, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

AgilentAgilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors. The company operates through three segments: Life Sciences and Diagnostics Markets (which includes contract manufacturing services for oligonucleotide therapeutics and pathology solutions), Agilent CrossLab (providing lab services and automation), and Applied Markets (offering analytical instruments and software).

Companies working in the same space as Trialtus Bioscience.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2021	$256.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Trialtus Bioscience do?: Trialus Bioscience provides protein purification products and services for laboratory and research applications.
Who are Trialtus Bioscience's investors?: Trialtus Bioscience's investors include Innovation Depot.
How much funding has Trialtus Bioscience raised?: Trialtus Bioscience has disclosed $1.6M raised across 1 round.
Where is Trialtus Bioscience headquartered?: Trialtus Bioscience is headquartered in Birmingham, US.